Buscar
Mostrando ítems 21-30 de 292
Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients
(Springer, 2020-10)
Background: Proton pump inhibitors (PPI)-related hypomagnesemia is a potentially life-threatening adverse event first described in 2006. PPIs are widely used in the general population. Information regarding prevalence and ...
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study
(Elsevier, 2015-03)
BACKGROUND & AIM Retrospective studies show an association between proton pump inhibitor (PPI) therapy and spontaneous bacterial peritonitis (SBP). We investigate the relationship between PPI and SBP in decompensated ...
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard
(Ecv-editio Cantor Verlag Medizin Naturwissenschaften, 2004-01-01)
An analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection was developed for the determination of pantoprazole (CAS 102625-70-7) in ...
The influence of omeprazole on the dissolution processes of ph-dependent magnetic tablets assessed by pharmacomagnetography
(2021-08-01)
Pharmacomagnetography involves the simultaneous assessment of solid dosage forms (SDFs) in the human gastrointestinal (GI) tract and the drug plasmatic concentration, using a biomagnetic technique and pharmacokinetics ...
Consumo prolongado de inhibidores de bomba de protones como factor de riesgo para síndrome de intestino irritable en pacientes adultos
(Universidad Privada Antenor OrregoPE, 2022)
Determinar que el consumo prolongado de inhibidores de
bomba de protones es un factor de riesgo para síndrome de intestino
irritable en pacientes adultos.
Material y Métodos: Se llevó a cabo un estudio de casos y ...
Reposicionamento de medicamentos em doenças infecciosas e avaliação da atividade biológica de inibidores da bomba de prótons e benzodiazepínicos
(Universidade Federal de Santa MariaBrasilAnálises Clínicas e ToxicológicasUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da Saúde, 2022-09-22)
A pathological condition with a high level of severity, caused by drug resistance, is one of the major public health
problems worldwide and has worrying consequences. This scenario becomes more complex when we mention ...
Diminished Mycophenolic Acid Exposure Caused by Omeprazole May Be Clinically Relevant in the First Week Posttransplantation
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Background: Some studies have reported a decreased absorption of mycophenolic acid (MPA) from mycophenolate mofetil (MMF) in renal transplanted (RTx) patients under proton-pump inhibitors (PPIs). There is still a lack of ...
Systematic review: proton pump inhibitor-associated acuteinterstitial nephritis
(Wiley-BlackwellAlimentary pharmacology and therapeutics, 2007)
Asociación entre la exposición prolongada a inhibidores de la bomba de protones y la prescripción de medicamentos para el abordaje de la osteoporosis en pacientes adultos asegurados al sistema de salud colombiano
Background: In the past years the proton pump inhibitors have raised a paramount interest in the medical literature due to its adverse events; however, available observational studies do not allow to conclude if they are ...